Simulations Plus Inc (SLP)Healthcare | Health Information Services | Research Triangle Park, United States |
USD
|
Hot Take ↕ | Oct. 10, 2026, 10:46 a.m. UTC
The investment thesis here is fundamentally broken by the pending acquisition. While the company boasts a pristine balance sheet with minimal debt and strong cash generation, the market has priced in a definitive exit strategy rather than organic growth. The news of a $375 million cash buyout at a 26% premium creates a binary outcome: the stock will likely gap up to reflect the offer price, or remain stagnant if the deal faces regulatory hurdles or shareholder rejection. With only one analyst offering a 'Hold' and a target price identical to the current price, there is no margin of safety for a long-term holder waiting for earnings growth. The short-term outlook is neutral to slightly negative due to the uncertainty surrounding the deal's finalization and the potential for a 'sell the news' event once the premium is fully realized. There is no dividend to provide income, and the lack of institutional accumulation suggests the smart money is waiting for the merger to close before taking a definitive side. Given the ambiguity and the fact that the current price already reflects the buyout premium, holding for capital appreciation is a gamble on the deal's success rather than a bet on business quality. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.003169 |
| AutoETS | 0.003169 |
| MSTL | 0.004272 |
| AutoTheta | 0.052181 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 46% |
| H-stat | 7.22 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.274 |
| Excess Kurtosis | -0.15 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2024-07-29 |
| Last Dividend Date | 2024-07-29 |
| Debt to Equity Ratio | 0.35 |
| Revenue per Share | 4.07 |
| Market Cap | 374,159,488 |
| Trailing P/E | 46.25 |
| Forward P/E | 20.90 |
| Beta | 1.32 |
| Profit Margins | 9.88% |
| Website | https://www.simulations-plus.com |
As of Oct. 10, 2026, 10:46 a.m. UTC: Speculator positioning is heavily skewed toward calls, with significant open interest concentrated at the $20 strike across multiple expirations, suggesting a bullish bias or a 'long gamma' setup at that level. Conversely, put activity is negligible, indicating a lack of hedging demand or bearish conviction. Implied volatility is flat at zero for most strikes, which distorts standard IV analysis but highlights a lack of active pricing for directional moves.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.1548065 |
| Address1 | 800 Park Offices Drive |
| Address2 | Suite 401 |
| All Time High | 90.92 |
| All Time Low | 0.14075 |
| Ask | 18.5 |
| Ask Size | 900 |
| Audit Risk | 5 |
| Average Daily Volume10 Day | 312,411 |
| Average Volume | 273,993 |
| Average Volume10Days | 312,411 |
| Beta | 1.315 |
| Bid | 18.49 |
| Bid Size | 800 |
| Board Risk | 4 |
| Book Value | 6.877 |
| City | Research Triangle Park |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Currency | USD |
| Current Price | 18.5 |
| Current Ratio | 5.538 |
| Date Short Interest | 1,789,430,400 |
| Day High | 18.5 |
| Day Low | 18.49 |
| Debt To Equity | 0.35 |
| Dividend Yield | 0.0 |
| Ebitda | 15,016,000 |
| Ebitda Margins | 0.18299 |
| Enterprise To Ebitda | 21.621 |
| Enterprise To Revenue | 3.956 |
| Enterprise Value | 324,656,512 |
| Ex Dividend Date | 1,722,211,200 |
| Exchange | NMS |
| Exchange Timezone Name | UTC |
| Fifty Day Average | 18.402 |
| Fifty Two Week High | 21.01 |
| Fifty Two Week Low | 11.09 |
| Financial Currency | USD |
| First Trade Date Epoch Utc | 1,784,295,000 |
| Five Year Avg Dividend Yield | 0.53 |
| Float Shares | 16,809,267 |
| Forward Eps | 0.885 |
| Forward P E | 20.903955 |
| Free Cashflow | 18,406,624 |
| Full Time Employees | 212 |
| Fullday Change | 0.0 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 18.5 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.63376 |
| Gross Profits | 52,005,000 |
| Held Percent Insiders | 0.16912001 |
| Held Percent Institutions | 0.79235 |
| Implied Shares Outstanding | 20,224,838 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Last Dividend Date | 1,722,211,200 |
| Last Dividend Value | 0.06 |
| Last Fiscal Year End | 1,756,598,400 |
| Last Split Date | 1,191,283,200 |
| Last Split Factor | 2:1 |
| Long Business Summary | Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina. As of October 6, 2026, Simulations Plus, Inc. was taken private. |
| Long Name | Simulations Plus Inc |
| Market Cap | 374,159,488 |
| Max Age | 86,400 |
| Message Board Id | finmb_366946 |
| Most Recent Quarter | 1,780,185,600 |
| Net Income To Common | 8,105,000 |
| Next Fiscal Year End | 1,788,134,400 |
| Non Diluted Market Cap | 372,541,515 |
| Number Of Analyst Opinions | 1 |
| Open | 0.0 |
| Operating Cashflow | 24,942,000 |
| Operating Margins | 0.22840999 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Peg Ratio | 9.88 |
| Phone | 661 723 7723 |
| Previous Close | 18.5 |
| Price Hint | 2 |
| Price To Book | 2.6901267 |
| Price To Sales Trailing12 Months | 4.5596952 |
| Profit Margins | 0.09877 |
| Quick Ratio | 5.307 |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Regular Market Day High | 18.5 |
| Regular Market Day Low | 18.49 |
| Regular Market Open | 0.0 |
| Regular Market Previous Close | 18.5 |
| Regular Market Volume | 0 |
| Return On Assets | 0.054819997 |
| Return On Equity | 0.061680004 |
| Revenue Growth | 0.075 |
| Revenue Per Share | 4.07 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 20,224,838 |
| Shares Percent Shares Out | 0.143 |
| Shares Short | 2,892,884 |
| Shares Short Previous Month Date | 1,786,665,600 |
| Shares Short Prior Month | 2,818,580 |
| Short Name | Simulations Plus, Inc. |
| Short Percent Of Float | 0.24610001 |
| Short Ratio | 16.25 |
| State | NC |
| Symbol | SLP |
| Target High Price | 18.5 |
| Target Low Price | 18.5 |
| Target Mean Price | 18.5 |
| Target Median Price | 18.5 |
| Time Zone Full Name | America/New_York |
| Time Zone Short Name | EDT |
| Total Cash | 49,990,000 |
| Total Cash Per Share | 2.472 |
| Total Debt | 487,000 |
| Total Revenue | 82,058,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.4 |
| Trailing P E | 46.25 |
| Trailing Peg Ratio | None |
| Two Hundred Day Average | 16.263525 |
| Underlying Symbol | SLP |
| Uuid | fdc1976c-6b80-3a0e-9129-b43bc4d9255c |
| Volume | 0 |
| Website | https://www.simulations-plus.com |
| Zip | 27,709 |